Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Dalfampridine Er
Dalfampridine Er Image

Dalfampridine Er

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Dalfampridine Er?

Dalfampridine ER, also known by its brand name Ampyra, is a medication that falls under the class of Multiple Sclerosis Agents - Potassium Channel Blockers. It is primarily used to improve walking ability in patients with multiple sclerosis (MS). This medication is manufactured by MICRO LABORATORIES. Dalfampridine ER works by blocking certain potassium channels in the nervous system, which helps improve the conduction of nerve signals to the muscles involved in walking. This can lead to increased walking speed and improved overall mobility in individuals with MS. It is important to mention that Dalfampridine ER is not a cure for multiple sclerosis and does not address the underlying causes of the disease. It is solely intended to provide symptomatic relief by targeting walking difficulties. Additionally, this medication is not suitable for everyone and should be used under the guidance of a healthcare professional, as it can have side effects such as seizures, urinary tract infections, and elevated liver enzymes. As with any medication, it is crucial to follow the prescribed dosage and consult with a healthcare provider for a personalized treatment plan.

How to use Dalfampridine Er?

Dalfampridine ER is an extended-release tablet that is typically used to improve walking in individuals with multiple sclerosis (MS). It is commonly sold under the brand name Ampyra. Here are some important considerations regarding the usage of this medication: 1. Always take Dalfampridine ER exactly as prescribed by your healthcare provider. Do not change the dosage without consulting them. 2. The tablet should be taken orally, usually once every 12 hours. It is important to follow the prescribed dosing schedule to ensure effectiveness and minimize the risk of side effects. 3. Dalfampridine ER can be taken with or without food. However, it is advisable to be consistent with your choice to maintain consistency in drug absorption. 4. Swallow the tablet whole and avoid crushing, chewing, or breaking it. Doing so may interfere with the drug's extended-release mechanism and affect its effectiveness. 5. Dalfampridine ER is generally initiated at a low dose and then gradually increased as per your healthcare provider's instructions. It may take several weeks for you to notice any improvement in your walking ability. 6. If you miss a dose, take it as soon as you remember unless it is already close to the time for your next dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not double the dose to compensate for a missed one. 7. It is important to inform your healthcare provider about any other medications, supplements, or herbal products you may be taking, as they can potentially interact with Dalfampridine ER. 8. Contact your healthcare provider if you experience any unusual or severe side effects. Common side effects may include seizures, urinary tract infections, insomnia, dizziness, and headache. Remember, Dalfampridine ER is a prescription medication for MS-related walking difficulties, and proper medical guidance should always be sought before initiating or making any changes to the treatment plan.

Dalfampridine ER, commonly known as Ampyra, is a medication primarily used to improve the walking ability in individuals with multiple sclerosis (MS). However, there are certain warnings associated with its use that should be taken into consideration. Firstly, it's important to note that Ampyra should not be used in individuals with a history of seizures or who have moderate to severe kidney impairment. This medication has the potential to lower the seizure threshold, increasing the risk of seizures in susceptible individuals. Therefore, it is crucial to inform your healthcare provider about any history of seizures or kidney problems before starting this medication. Additionally, Ampyra can cause an increase in blood pressure, so it is essential to monitor blood pressure regularly while taking this medication. Individuals with a history of hypertension or cardiovascular disease should be closely monitored by their healthcare provider. Other potential side effects of Ampyra include urinary tract infections, dizziness, insomnia, headache, and gastrointestinal issues. It is important to report any unexpected or severe side effects to your healthcare provider promptly. Lastly, Ampyra is a prescription medication and should only be used under the supervision and guidance of a healthcare professional. Dosage adjustments and regular evaluations may be necessary to ensure the safe and effective use of this medication. As with any medication, it is important to consult with a healthcare provider to discuss individual risks, benefits, and any specific warnings or precautions associated with the use of Dalfampridine ER.

Before taking Dalfampridine ER (Extended Release), also known as Ampyra, it's important to be aware of certain warnings and precautions associated with this medication. Here are some key points to consider: 1. Allergies: Inform your healthcare provider if you have any known allergies to Dalfampridine ER or any of its ingredients. This medication may contain inactive ingredients that could potentially cause allergic reactions. 2. Kidney problems: Notify your doctor if you have any kidney problems or if you are on dialysis. Dalfampridine ER should be used with caution in individuals with impaired kidney function. 3. Seizures: Dalfampridine ER may lower the seizure threshold, increasing the risk of seizures. Discuss your seizure history with your healthcare provider before starting this medication. 4. Urinary tract infections: Dalfampridine ER has been associated with an increased risk of urinary tract infections. Inform your doctor if you have a history of urinary tract infections or experience symptoms such as pain or burning during urination. 5. Drug interactions: It's important to inform your doctor about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. Dalfampridine ER may interact with certain medications, potentially leading to complications. 6. Pregnancy and breastfeeding: The safety and effectiveness of Dalfampridine ER during pregnancy and breastfeeding are not well-established. Consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. 7. Potential side effects: Dalfampridine ER may cause side effects such as seizures, dizziness, insomnia, and urinary tract infections. If you experience any unusual or severe side effects, contact your healthcare provider immediately. Remember, this information does not replace the advice of a healthcare professional. It is crucial to consult your doctor or pharmacist for personalized guidance and to thoroughly discuss the potential risks and benefits of taking Dalfampridine ER.

Dalfampridine ER, also known by its brand name Ampyra, is a medication primarily used to improve walking in individuals with multiple sclerosis (MS). It belongs to the class of drugs known as potassium channel blockers. Like any medication, Dalfampridine ER can potentially cause side effects. Some common side effects of this drug include: 1. Urinary tract infection 2. Insomnia (difficulty sleeping) 3. Dizziness 4. Headache 5. Nausea 6. Fatigue 7. Back pain 8. Balance disturbances It is important to note that not everyone will experience these side effects, and some individuals may experience different or no side effects at all. If you are prescribed Dalfampridine ER and notice any unusual or bothersome side effects, it is recommended to speak with your healthcare provider. They can provide further guidance and address any concerns you may have.

Dalfampridine ER, also known by its brand name Ampyra, is a medication used to improve walking in people with multiple sclerosis (MS). The active ingredient in Dalfampridine ER is dalfampridine, which is a potassium channel blocker. In addition to dalfampridine, the other ingredients found in the medication may vary depending on the manufacturer. However, the inactive ingredients commonly found in Dalfampridine ER tablets include: 1. Hypromellose: This is a hydrophilic polymer that helps to control the release of the active ingredient in the body. 2. Microcrystalline cellulose: It acts as a filler and binder in the tablet. 3. Colloidal silicon dioxide: This is an anti-caking agent that improves the flow of the powder during manufacturing. 4. Stearic acid: It is a lubricant that helps to prevent the tablet from sticking to the machinery during production. 5. Magnesium stearate: This is another lubricant that assists in the tablet manufacturing process. It is important to note that the specific ingredients and formulations may vary among different generic manufacturers of Dalfampridine ER. Therefore, it is crucial to consult the product packaging or refer to the specific drug information provided by the manufacturer for the most accurate and up-to-date information.

Dalfampridine ER, also known by the brand name Ampyra, is a medication used in the treatment of multiple sclerosis (MS). Proper storage of this drug is important to ensure its effectiveness and safety. Dalfampridine ER should be stored at room temperature, between 68°F and 77°F (20°C and 25°C). It is important to keep the medication in a dry place, away from moisture and direct sunlight, as these conditions can affect its stability. It is recommended to store the medication in its original container, tightly closed, and out of reach of children and pets. This is to prevent accidental ingestion and ensure the medication is not exposed to external elements that may alter its composition or potency. If you have any expired or unused Dalfampridine ER, it is recommended to dispose of it properly. You can consult with your pharmacist or local waste disposal facility to learn about the correct methods of medication disposal, as some medications may require specific procedures. Remember to always check the expiration date before using Dalfampridine ER, as using expired medication may not provide the desired therapeutic effect and can potentially be harmful. If you have any doubts about the storage or use of this medication, it is best to consult with your healthcare provider or pharmacist for guidance.

Similar Drugs

Our philosophy is simple — hire a team of diverse, passionate people and foster a culture that empowers you to do your best